Peptide CDMOs in India

Contract Development and Manufacturing Organizations (CDMOs) specializing in peptide synthesis from clinical batches to commercial-scale production. Ideal for pharmaceutical and biotech enterprises requiring GMP-compliant facilities and regulatory support. CDMOs typically hold FDA and EMA inspected facilities covering solid-phase synthesis, purification, lyophilization, and analytical method development. Major peptide CDMOs serve both innovator drug developers and generic API customers across metabolic disease, oncology, and endocrinology therapeutic areas. Bachem, PolyPeptide, Lonza, CordenPharma, and WuXi AppTec represent the largest global CDMO capacity for peptide active pharmaceutical ingredients. Showing 15 suppliers listed in India.

Browse Peptide CDMOs operating in India serving pharmaceutical, biotech, and research customers. These suppliers offer India-based manufacturing, distribution, and quality control for peptide products including Piramal Pharma Solutions, Divi's Laboratories, Aragen Life Sciences and other vetted providers. Sourcing from India-based peptide cdmos provides advantages in regulatory compliance, shipping timelines, and supply chain transparency for buyers in this region.